Schedule 13G ownership disclosure

REXAHN PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 761640101

Event date: 2016-02-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
10,425,000
Percent of class
4.8900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000141
Form type
SC 13G
Filer
Opus Genetics, Inc.
CIK
CIK 1228627
Filed
Feb 29, 2016
Reporting period
Feb 26, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub